A Revolutionary Retinal Laser for RPE Regeneration (#619)
R:GEN®
A Revolutionary Retinal Laser for RPE Regeneration
Lutronic Vision, a LUTRONIC eye healthcare dedicated subsidiary, is bringing to market the world’s first Selective Retina Therapy laser with Real-time Feedback Technology™ named R:GEN® for the treatment of retinal diseases. With an ideal laser source and proprietary RTF™ technology R:GEN® is designed to selectively damage RPE cells while sparing other retinal tissues, and triggers RPE cell regeneration and functional recovery. The safety and effectiveness of R:GEN® treatment for Diabetic Macular Edema, Central Serous Chorioretinopathy, and Dry Age-related Macular Degeneration were demonstrated in many clinical studies.
R:GEN® is the first FDA-approved retinal laser with RTF™ technology for Clinically Significant Macular Edema. The device also holds CE Marking for Dry Age-related Macular Degeneration, Central Serous Chorioretinopathy, and Diabetic Macular Edema.
For more information, please visit our website www.lutronicvision.com'
Brands: R:GEN® & RTF Sensor